{"count": 10, "results": [{"_id": "35219642", "pmid": 35219642, "title": "Atenolol as treatment for hepatic hemangiomas in a premature infant.", "journal": "Pediatr Neonatol", "authors": ["Der Sarkissian S", "Ge L", "Sun HY", "Chen MKY", "Sebaratnam DF"], "date": "2022-05-01T00:00:00Z", "doi": "10.1016/j.pedneo.2021.12.002", "meta_date_publication": "2022 May", "meta_volume": "63", "meta_issue": "3", "meta_pages": "317-318", "score": 50290.426, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ as treatment for @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hepatic hemangiomas@@@ in a premature infant.", "citations": {"NLM": "Der Sarkissian S, Ge L, Sun HY, Chen MKY, Sebaratnam DF. Atenolol as treatment for hepatic hemangiomas in a premature infant. Pediatr Neonatol. 2022 May;63(3):317-318. PMID: 35219642", "BibTeX": "@article{35219642, title={Atenolol as treatment for hepatic hemangiomas in a premature infant.}, author={Der Sarkissian S and Ge L and Sun HY and Chen MKY and Sebaratnam DF}, journal={Pediatr Neonatol}, volume={63}, number={3}, pages={317-318}}"}}, {"_id": "33423413", "pmid": 33423413, "title": "Clinical evaluation of infantile hemangiomas treated with atenolol.", "journal": "Dermatol Online J", "authors": ["Ballona R", "Zevallos J", "Núñez J"], "date": "2020-12-15T00:00:00Z", "meta_date_publication": "2020 Dec 15", "meta_volume": "26", "meta_issue": "12", "meta_pages": "", "score": 50267.996, "text_hl": "Clinical evaluation of @DISEASE_Hemangioma_capillary_infantile @DISEASE_MESH:C535860 @@@infantile hemangiomas@@@ treated with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Ballona R, Zevallos J, Núñez J. Clinical evaluation of infantile hemangiomas treated with atenolol. Dermatol Online J. 2020 Dec 15;26(12):. PMID: 33423413", "BibTeX": "@article{33423413, title={Clinical evaluation of infantile hemangiomas treated with atenolol.}, author={Ballona R and Zevallos J and Núñez J}, journal={Dermatol Online J}, volume={26}, number={12}}"}}, {"_id": "33429792", "pmid": 33429792, "pmcid": "PMC7793351", "title": "A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China", "journal": "Medicine (Baltimore)", "authors": ["Zhao ZL", "Liu C", "Wang QZ", "Zhang WB", "Shao L", "Wu HW", "Zheng JW"], "date": "2021-01-08T00:00:00Z", "doi": "10.1097/MD.0000000000024146", "meta_date_publication": "2021 Jan 8", "meta_volume": "100", "meta_issue": "1", "meta_pages": "e24146", "score": 50265.457, "text_hl": "A survey on the application of oral @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for the management of @DISEASE_Hemangioma_capillary_infantile @DISEASE_MESH:C535860 @@@infantile hemangiomas@@@ in mainland China: survey on @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangiomas@@@. ", "citations": {"NLM": "Zhao ZL, Liu C, Wang QZ, Zhang WB, Shao L, Wu HW, Zheng JW. A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China Medicine (Baltimore). 2021 Jan 8;100(1):e24146. PMID: 33429792", "BibTeX": "@article{33429792, title={A survey on the application of oral propranolol and atenolol for the management of infantile hemangiomas in mainland China}, author={Zhao ZL and Liu C and Wang QZ and Zhang WB and Shao L and Wu HW and Zheng JW}, journal={Medicine (Baltimore)}, volume={100}, number={1}, pages={e24146}}"}}, {"_id": "38061014", "pmid": 38061014, "title": "Oral atenolol compared to oral propranolol for infantile hemangioma.", "journal": "Medwave", "authors": ["Meza Viteri V", "Aranibar L"], "date": "2023-12-07T00:00:00Z", "doi": "10.5867/medwave.2023.11.2753", "meta_date_publication": "2023 Dec 7", "meta_volume": "23", "meta_issue": "11", "meta_pages": "e2753", "score": 50261.83, "text_hl": "Conclusion: The use of oral @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ compared with oral @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ as monotherapies may result in little or no difference in terms of likelihood of complete remission, decrease in @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@Hemangioma@@@ Activity Score, likelihood of post-treatment relapse, and risk of adverse events and severe adverse events, in @DISEASE_Hemangioma_capillary_infantile @DISEASE_MESH:C535860 @@@infantile hemangioma@@@ (low certainty of evidence).", "citations": {"NLM": "Meza Viteri V, Aranibar L. Oral atenolol compared to oral propranolol for infantile hemangioma. Medwave. 2023 Dec 7;23(11):e2753. PMID: 38061014", "BibTeX": "@article{38061014, title={Oral atenolol compared to oral propranolol for infantile hemangioma.}, author={Meza Viteri V and Aranibar L}, journal={Medwave}, volume={23}, number={11}, pages={e2753}}"}}, {"_id": "33856430", "pmid": 33856430, "title": "Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.", "journal": "JAMA Otolaryngol Head Neck Surg", "authors": ["Ji Y", "Chen S", "Yang K", "Zhang X", "Zhou J", "Li L", "Xiang B", "Qiu T", "Dai S", "Jiang X", "Lu G", "Qiu L", "Kong F", "Zhang Y"], "date": "2021-07-01T00:00:00Z", "doi": "10.1001/jamaoto.2021.0454", "meta_date_publication": "2021 Jul 1", "meta_volume": "147", "meta_issue": "7", "meta_pages": "599-607", "score": 50258.23, "text_hl": "At 1 and 4 weeks after treatment, and thereafter, the @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangioma@@@ activity score in the @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ group aligned with the @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ group (odds ratio, 1.034; 95% CI, 0.886-1.206). ", "citations": {"NLM": "Ji Y, Chen S, Yang K, Zhang X, Zhou J, Li L, Xiang B, Qiu T, Dai S, Jiang X, Lu G, Qiu L, Kong F, Zhang Y. Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial. JAMA Otolaryngol Head Neck Surg. 2021 Jul 1;147(7):599-607. PMID: 33856430", "BibTeX": "@article{33856430, title={Efficacy and Safety of Propranolol vs Atenolol in Infants With Problematic Infantile Hemangiomas: A Randomized Clinical Trial.}, author={Ji Y and Chen S and Yang K and Zhang X and Zhou J and Li L and Xiang B and Qiu T and Dai S and Jiang X and Lu G and Qiu L and Kong F and Zhang Y}, journal={JAMA Otolaryngol Head Neck Surg}, volume={147}, number={7}, pages={599-607}}"}}, {"_id": "35466712", "pmid": 35466712, "title": "Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.", "journal": "Ann Otol Rhinol Laryngol", "authors": ["Chen T", "Gudipudi R", "Nguyen SA", "Carroll W", "Clemmens C"], "date": "2022-04-25T00:00:00Z", "doi": "10.1177/00034894221089758", "meta_date_publication": "2022 Apr 25", "meta_volume": "", "meta_issue": "", "meta_pages": "34894221089758", "score": 50257.996, "text_hl": "All randomized control trials (RCTs) or cohort studies directly comparing outcomes of @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangioma@@@ treatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ were included. ", "citations": {"NLM": "Chen T, Gudipudi R, Nguyen SA, Carroll W, Clemmens C. Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol. Ann Otol Rhinol Laryngol. 2022 Apr 25;():34894221089758. PMID: 35466712", "BibTeX": "@article{35466712, title={Should Propranolol Remain the Gold Standard for Treatment of Infantile Hemangioma? A Systematic Review and Meta-Analysis of Propranolol Versus Atenolol.}, author={Chen T and Gudipudi R and Nguyen SA and Carroll W and Clemmens C}, journal={Ann Otol Rhinol Laryngol}, pages={34894221089758}}"}}, {"_id": "34874911", "pmid": 34874911, "pmcid": "PMC8803322", "title": "Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma", "journal": "J Clin Invest", "authors": ["Seebauer CT", "Graus MS", "Huang L", "McCann A", "Wylie-Sears J", "Fontaine F", "Karnezis T", "Zurakowski D", "Staffa SJ", "Meunier F", "Mulliken JB", "Bischoff J", "Francois M"], "date": "2022-02-01T00:00:00Z", "doi": "10.1172/JCI151109", "meta_date_publication": "2022 Feb 1", "meta_volume": "132", "meta_issue": "3", "meta_pages": "", "score": 50257.137, "text_hl": "We investigated the effect of R(+) enantiomers of @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ on the formation of @DISEASE_Hemangioma_capillary_infantile @DISEASE_MESH:C535860 @@@IH@@@-like blood vessels from @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangioma@@@ stem cells (HemSCs) in a @SPECIES_10090 @@@murine@@@ xenograft model. ", "citations": {"NLM": "Seebauer CT, Graus MS, Huang L, McCann A, Wylie-Sears J, Fontaine F, Karnezis T, Zurakowski D, Staffa SJ, Meunier F, Mulliken JB, Bischoff J, Francois M. Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma J Clin Invest. 2022 Feb 1;132(3):. PMID: 34874911", "BibTeX": "@article{34874911, title={Non-beta blocker enantiomers of propranolol and atenolol inhibit vasculogenesis in infantile hemangioma}, author={Seebauer CT and Graus MS and Huang L and McCann A and Wylie-Sears J and Fontaine F and Karnezis T and Zurakowski D and Staffa SJ and Meunier F and Mulliken JB and Bischoff J and Francois M}, journal={J Clin Invest}, volume={132}, number={3}}"}}, {"_id": "40047218", "pmid": 40047218, "title": "Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review.", "journal": "Dermatol Reports", "authors": ["Alruhaimi S", "Alowirdi F", "Al-Ajroush W"], "date": "2025-03-05T00:00:00Z", "doi": "10.4081/dr.2025.10239", "meta_date_publication": "2025 Mar 5", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50239.46, "text_hl": "The @SPECIES_9606 @@@patient@@@ was switched to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, which resulted in improvement of the @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangioma@@@ and complete resolution of the @DISEASE_Skin_Diseases @DISEASE_MESH:D012871 @@@skin lesions@@@. ", "citations": {"NLM": "Alruhaimi S, Alowirdi F, Al-Ajroush W. Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review. Dermatol Reports. 2025 Mar 5;():. PMID: 40047218", "BibTeX": "@article{40047218, title={Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review.}, author={Alruhaimi S and Alowirdi F and Al-Ajroush W}, journal={Dermatol Reports}}"}}, {"_id": "24431932", "pmid": 24431932, "title": "Beta-blockers for the treatment of problematic hemangiomas.", "journal": "Can J Plast Surg", "authors": ["Sharma VK", "Fraulin FO", "Dumestre DO", "Walker L", "Harrop AR"], "date": "2013-04-01T00:00:00Z", "doi": "10.1177/229255031302100103", "meta_date_publication": "2013 Spring", "meta_volume": "21", "meta_issue": "1", "meta_pages": "23-8", "score": 50063.805, "text_hl": "Beta-blockers for the treatment of problematic @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangiomas@@@.", "citations": {"NLM": "Sharma VK, Fraulin FO, Dumestre DO, Walker L, Harrop AR. Beta-blockers for the treatment of problematic hemangiomas. Can J Plast Surg. 2013 Spring;21(1):23-8. PMID: 24431932", "BibTeX": "@article{24431932, title={Beta-blockers for the treatment of problematic hemangiomas.}, author={Sharma VK and Fraulin FO and Dumestre DO and Walker L and Harrop AR}, journal={Can J Plast Surg}, volume={21}, number={1}, pages={23-8}}"}}, {"_id": "29479946", "pmid": 29479946, "title": "New therapies for vascular anomalies of the gastrointestinal tract.", "journal": "Minerva Pediatr", "authors": ["Fox VL"], "date": "2018-06-01T00:00:00Z", "doi": "10.23736/S0026-4946.18.05207-6", "meta_date_publication": "2018 Jun", "meta_volume": "70", "meta_issue": "3", "meta_pages": "303-307", "score": 50040.324, "text_hl": "Important new pharmacological therapies include treatment of @<m>DISEASE_Hemangioma</m> @DISEASE_MESH:D006391 @@@hemangioma@@@ with non-selective and selective beta-antagonist agents, @CHEMICAL_Propranolol @CHEMICAL_MESH:D011433 @@@propranolol@@@ and @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@, and treatment of @DISEASE_Blue_rubber_bleb_nevus_syndrome @DISEASE_MESH:C536240 @@@blue rubber bleb nevus syndrome@@@ and @DISEASE_Angiomatosis @DISEASE_MESH:D000798 @@@cutaneo-visceral angiomatosis with thrombocytopenia@@@ (also known as @DISEASE_Thrombocytopenia @DISEASE_MESH:D013921 @@@multifocal lymphangioendotheliomatosis with thrombocytopenia@@@) with @CHEMICAL_Sirolimus @CHEMICAL_MESH:D020123 @@@sirolimus@@@, an inhibitor of the @GENE_MTOR @GENE_2475 @@@mammalian target of rapamycin@@@. ", "citations": {"NLM": "Fox VL. New therapies for vascular anomalies of the gastrointestinal tract. Minerva Pediatr. 2018 Jun;70(3):303-307. PMID: 29479946", "BibTeX": "@article{29479946, title={New therapies for vascular anomalies of the gastrointestinal tract.}, author={Fox VL}, journal={Minerva Pediatr}, volume={70}, number={3}, pages={303-307}}"}}]}